Covid-19 Epidemic on Acute Stroke Management (Stroke-Covid19)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04370197|
Recruitment Status : Recruiting
First Posted : April 30, 2020
Last Update Posted : April 30, 2020
The Covid-19 pandemic is a pandemic of an emerging infectious disease, coronavirus 2019 (Covid-19), caused by the coronavirus SARS-CoV-2. It appears in November 2019 in the city of Wuhan, China, and spreads worldwide from February 2020. The first cases of infection in France were confirmed on 24 January 2020. As of April 14, 103,573 cases of infection were confirmed, 32,292 hospitalized cases, including 6,730 in intensive care, with 15,729 deaths recorded1. The most affected regions are Ile de France and the Grand Est (in particular the Haut-Rhin department). Containment of the entire French population was introduced on 17 March, with the aim of reducing the spread of the virus and relieving the burden on the health system, particularly the intensive care units.
This unprecedented health crisis, as well as the social containment measures in themselves, has repercussions on other acute medical pthologies, not directly related to the viral infection. It appears that the number of patients treated for acute stroke has suddenly declined since the beginning of the epidemic.
However, it is not clear whether it is the incidence of stroke that has declined or simply the proportion of patients presenting within the time frame that allows for treatment in the acute phase (by thrombolysis or thrombectomy).
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Impact of th Covid-19 Epidemic on Acute Stroke Management|
|Actual Study Start Date :||March 3, 2020|
|Estimated Primary Completion Date :||April 30, 2020|
|Estimated Study Completion Date :||April 30, 2020|
- Study of the effect of pandemic covid-19 on the management of stroke patients [ Time Frame: 1 month ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04370197
|Contact: Rémy BEAUJEUX, MD, PhD||33 3 88 12 78 firstname.lastname@example.org|
|Contact: Saïd CHAYER, PhD, HDR||33 3 88 11 66 email@example.com|
|Service de Neuroradiologie Interventionnelle||Recruiting|
|Strasbourg, France, 67091|
|Contact: Rémy BEAUJEUX, MD, PhD 33 3 88 12 78 71 firstname.lastname@example.org|
|Contact: Raoul POP, MD 33 3 88 12 78 71 email@example.com|
|Principal Investigator: Rémy BEAUJEUX, MD, PhD|
|Sub-Investigator: Raoul POP, MD|